Efficacy and safety of sacubitril/valsartan on heart failure with preserved ejection fraction: A meta-analysis of randomized controlled trials

AIMS: The efficacy and safety of sacubitril/valsartan for patients with heart failure with preserved ejection fraction (HFpEF) are controversial. Hence, the primary objective of the study was to evaluate the efficacy and safety of sacubitril/valsartan treatment for patients with HFpEF. METHODS AND R...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Wanqian, Zhang, Hongzhou, Shen, Wen, Luo, Fan, Yang, Shuai, Gan, Lujin, Zhao, Yuanbin, Yang, Pingping, Wu, Qinghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492872/
https://www.ncbi.nlm.nih.gov/pubmed/36158828
http://dx.doi.org/10.3389/fcvm.2022.897423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492872/
https://www.ncbi.nlm.nih.gov/pubmed/36158828
http://dx.doi.org/10.3389/fcvm.2022.897423

Ejemplares similares